baber/WOPTO huggingface dataset:
Patent NZ-549416-A (NZ)
Title: Improved roofing tile
Inventor: POWELL STEPHEN JOHN
Filed: 2006-08-24
Abstract: A roofing tile having opposed sides, at least one of the sides having a side portion that is adapted to overlap with a side portion of a like tile, but maintain an air gap between the portions, when positioned as a course of tiles on a roof. The surface of the tile portion that would be juxtaposed to a surface of a like tile when in a course of tiles is at least partly coated with a surface sealant to reduce the surface tension of water when compared to a normal tile surface.
Patent NZ-550007-A (NZ)
Title: Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
Inventor: ABOUABDELLAH AHMED
IPC: C07D211/34
Filed: 2005-02-25
Abstract: The disclosure relates to enzyme inhibitors and their use in the treatment and therapy of a wide variety of diseases and degenerative conditions. More particularly, it is directed towards the use of piperidinylalkylcarbamates of formula (I), processes for their preparation and methods of use thereof as fatty acid amido hydrolase (FAAH) enzyme inhibitors in the treatment of arthritis, heart disease, cancer and the like and to their application in a wide variety of therapeutic regimens such as for the treatment of pain, inflammation, neurodegenerative diseases, etc.
Patent NZ-560812-A (NZ)
Title: Improvements in fruit harvesting equipment
Inventor: KING MATTHEW JAMES
Filed: 2007-05-11
Abstract: A fruit collector includes a flexible collection apron 30 that is supported by a plurality of battens 31 mounted on arms 32, the position of which can be adjusted by "scissor" mechanism 25, to move the apron between an extended fruit catching position and a compacted transport and fruit channelling position in which the opposite sides of the apron are brought together to define a channel to guide the fruit collected in the apron into a hopper. The arms are coupled to a mounting which is arranged to be coupled to a boom so that the collector can be positioned with the apron surrounding the trunk T of a fruit tree between the bifurcations 40 of the mounting. Tensioning ropes 33 control the movement of the apron between the extended and compacted positions.
Patent NZ-561073-A (NZ)
Title: Preparation of cabergoline polymorph
Inventor: GREENWOOD ALAN KENNETH
IPC: C07D457/06
Filed: 2006-03-23
Abstract: Disclosed is a method of preparing cabergoline Form I, comprising forming a solvate including cabergoline and a p-disubstituted benzene of formula (A), X is fluorine, and Y is selected from the group consisting of halogens or methyl, and obtaining cabergoline Form I from the solvate. Another disclosure also provides a method for preparing cabergoline Form I comprising dissolving cabergoline in p-disubstituted benzene and recovering the cabergoline Form I polymorph, suitably by direct crystallization of Form I or by recovery of a solvate which can be converted to Form I.
Patent NZ-565897-A (NZ)
Title: Methods for cleaning industrial equipment using a CIP process utilising a pre-treatment with peroxycarboxylic acids
Inventor: FERNHOLZ PETER J
IPC: A01J7/02
Filed: 2006-10-11
Abstract: Disclosed is a method of cleaning soils from industrial equipment using a CIP process, the method comprising: (a) applying a pre-treatment solution to the soil, the solution comprising at least 0.10 wt-% active ingredients, the active ingredients including a surfactant penetrant and a peroxycarboxylic acid oxidant, and optionally 0.10 to 1.5 wt-% of an acid selected from phosphoric acid, nitric acid, sulphuric acid, lactic acid, acetic acid, hydroxyacetic acid and citric acid, wherein the oxidant is selected from the group consisting of peroxypentanoic, peroxyhexanoic, peroxyheptanoic, peroxyoctanoic, peroxynonanoic, peroxyisononanoic, peroxydecanoic, peroxyundecanoic, peroxydodecanoic, peroxyascorbic, peroxyadipic, peroxycitric, peroxypimelic, peroxysuberic, peroxyisopentanoic, peroxyisononanoic, peroxyisohexanoic, peroxyisoheptanoic, peroxyisooctanoic, peroxyisonananoic, peroxyisodecanoic, peroxyisoundecanoic, peroxyisododecanoic, peroxyneopentanoic, peroxyneohexanoic, peroxyneoheptanoic, peroxyneooctanoic, peroxyneononanoic, peroxyneodecanoic, peroxyneoundecanoic, peroxyneododecanoic acid or combinations thereof; (b) allowing the pre-treatment solution to partially remain on the soil for a period of time sufficient to facilitate soil removal in step (c); (c) recirculating a second solution through the equipment after the pre-treatment solution, the second solution comprising a dilute detergent to at least partially remove the soil from the equipment; and; and then (d) rinsing the equipment.
Patent NZ-567747-A (NZ)
Title: [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
Inventor: SCARBOROUGH ROBERT M
IPC: A61K31/44
Filed: 2006-11-03
Abstract: Disclosed herein is [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea or a pharmaceutically acceptable salt or hydrate thereof, particularly sodium or potassium salts, methods for obtaining such salts and compositions comprising said compound. The compound is useful in the treatment or prevention of thrombosis and thrombosis related conditions, a condition or disorder mediated at least in part by ADP-induced platelet aggregation in a mammal, in particular cardiovascular diseases such as acute myocardial infarction, unstable angina, chronic stable angina, transient ischemic attacks, strokes, peripheral vascular disease, preeclampsia/eclampsia, deep venous thrombosis, embolism, disseminated intravascular coagulation and thrombotic cytopenic purpura, thrombotic and retenotic complications following invasive procedures resulting from angioplasty, carotid endarterectorny, post CABG (coronary artery bypass graft) surgery, vascular gram surgery, stent, in-stent thrombosis, and insertion of endovascular devices and prostheses, and hypercoagulable states related to genetic predisposition or cancers.
Patent NZ-574291-A (NZ)
Title: Pull tab for can opening with hinge lines adjacent finger pull
Inventor: TIELBEKE GERARDUS JOHANNES JOSEPHUS
IPC: B21D51/38
Filed: 2007-07-16
Abstract: The pull tab for a can closure has a tab body 5 with a tab nose 10 on one side for opening the closure and a tab lever 11 on the other side which is provided with a finger opening 12. The finger opening 12 is surrounded by a distal lever part 13 connected by lateral lever legs 14 to the tab body. The lever legs include aligned hinge parts 16 in the form of lateral lever leg parts of reduced bending strength. The bending strength of the lateral leg parts of reduced bending strength 27 increases toward the tab body in direction 28 so that despite repeated flexing of the lateral lever leg parts they do no tend to break.
Patent NZ-574326-A (NZ)
Title: Biocidal composition for leather tanning comprising 2(thiocyanomethylthio)-benzothiazole (tcmtb)
Inventor: IZQUIERDO RAMIS AMARO
IPC: A01P1/00
Filed: 2006-08-02
Abstract: Disclosed is a fungicide comprising a) 2-(thiocyanomethylthio)-benzothiazole b) methyl, ethyl or propyl ester of a C6-C20 fatty acid derived from vegetable oil and c) a surfactant The composition is used in leather tanning, to protect wood, paper, paperboard, cellulose pulp, cellulose products and for the prevention of slimes on materials, equipment and structures used in industrial processes.
Patent NZ-577332-A (NZ)
Title: Power level of transmitted control channel symbol
Inventor: COZZO CARMELA
IPC: H04L25/02
Filed: 2007-12-13
Abstract: A method of transmitting symbols used for channel estimation and a transmitter are disclosed. The transmitter comprises a baseband processor configured to adjust the power level of an enhanced dedicated physical control channel allocated to a receiver based on at least one of a transmission rate and a transport format of a physical data channel allocated to the receiver, and transmit control channel symbols to the receiver over the enhanced dedicated physical control channel at the adjusted power level for use by the receiver in performing channel estimation. A method of performing channel estimation at a receiver and a receiver are disclosed. The receiver comprises a baseband processor configured to detect control channel symbols received from an enhanced dedicated physical control channel allocated to the receiver at a power level corresponding to at least one of a transmission rate and a transport format of a physical data channel allocated to the receiver; and perform channel estimation based at least in part on the detected control channel symbols. The receiver is the mobile station 104 for downlink communication and the radio base station 102 for uplink communication and the transmitter is the radio base station 102 for downlink communication and the mobile station 104 for uplink communication.
Patent NZ-579375-A (NZ)
Title: Combination medicaments for treating bacterial infections
Inventor: DESARBRE ERIC
IPC: A61K31/427
Filed: 2008-03-19
Abstract: Disclosed is the use of (3S)-3-{ (2Z)-2-(2-amino(1,3-thiazol-4-yl))-3-[(1,5-dihydroxy-4-oxo(2-hydropyridyl))methoxy]-3-azaprop-2-enoylamino} -4,4-dimethyl-2-oxoazetidinyl hydroxysulfonate of formula (I) wherein the oxyimino group i.e. >C=N-O- has Z-orientation, or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a bacterial infection in combination with one or more than one carbapenem antibiotic, which is a compound of formula (II) e.g. meropenem where the substituents are defined in the specification.
Patent NZ-588191-A (NZ)
Title: Compounds and compositions as tlr activity modulators
Inventor: WU TOM YAO-HSIANG
IPC: A61K31/4375
Filed: 2009-02-27
Abstract: Provided is a naphtyridin compound of Formula (I-A), or pharmaceutically acceptable salt thereof, with defined substituents. The compound is a TLR activity modulator and can be used to treat various diseases (infectious diseases, inflammations, respiratory diseases, dermatological conditions or autoimmune diseases) involving immune system, as the drug is an immune potentiator.
Patent NZ-588342-A (NZ)
Title: An electrically heated smoking system having a liquid storage portion
Inventor: COCHAND OLIVIER YVES
IPC: A24F40/485
Filed: 2009-04-22
Abstract: 588342 Disclosed is an electrically heated smoking system with a shell (101) and a replaceable mouthpiece (201). The shell (101) includes an electric power supply (103) and electric circuitry (105) and the mouthpiece (211) contains a liquid storage portion (203), a capillary wick (207) having a first end and a second end such that the first end extending into the liquid storage portion (203) for contact with liquid (205). At least one heating element (209) is included for heating the second end of the capillary wick (207), an air outlet, and an aerosol forming chamber (213) between the second end of the capillary wick and the air outlet. When the shell (101) and mouthpiece (201) are engaged, the at least one heating element (209) is in electrical connection with the power supply via the circuitry (105). The circuitry (105) is arranged to provide an electric current pulse to the at least one heating element (209) when a user initiates a puff. A flow route for air is defined from at least one air inlet to the air outlet via the aerosol forming chamber (213), and the flow route channels the air flow around the heating element (209) and the second end of the capillary wick (207).
Patent NZ-589349-A (NZ)
Title: Hydrophilic and hydrophobic silane surface modification of abrasive grains
Inventor: SETH ANUJ
IPC: B24D3/20
Filed: 2009-04-16
Abstract: Abstract - 589349 Disclosed is a coated abrasive product, comprising: a) a backing layer; b) a make coat on the backing layer; and c) an abrasive grain component at the make coat, where the abrasive grain component includes abrasive grains surface-modified with at least one relatively hydrophilic silane component and at least one relatively hydrophobic silane component, wherein the relatively hydrophilic silane component includes at least one compound from at least one member selected from the group consisting of amines, diamines, triamines, azine, azol, ureido, isocyanate, alkoxy, acetoxy, oximino, chloro, morpholinyl and piperazinyl silanes, and wherein the relatively hydrophobic silane includes at least one compound from at least one member selected from the group consisting of vinyl silanes, methacrylate silanes, sulfur silanes, mercapto silanes, epoxy silanes and phenyl silanes, provided that the abrasive grains are not mica. Further disclosed is a method of forming a surface-modified abrasive grain, comprising the steps of: a) combining relatively hydrophilic and relatively hydrophobic silane components to form a mixture; b) combining the mixture with a solvent to form a silane solution; c) reacting at least a portion of the silane components to form a partially oligomerized silane solution; and d) blending the partially oligomerized silane solution with an abrasive grain component to form the surface-modified abrasive grain, wherein the relatively hydrophilic silane component includes at least one compound from at least one member selected from the group consisting of amines, diamines, triamines, azine, azol, ureido, isocyanate, alkoxy, acetoxy, oximino, chloro, morpholinyl and piperazinyl silanes, and wherein the relatively hydrophobic silane includes at least one compound from at least one member selected from the group consisting of vinyl silanes, methacrylate silanes, sulfur silanes, mercapto silanes, epoxy silanes and phenyl silanes, provided that the abrasive grain is not mica.
Patent NZ-589913-A (NZ)
Title: An arrangement to detect deformation of a wind turbine blade using a radio transmitter and antenna array
Inventor: GIERLICH ROLAND
IPC: F03D11/00
Filed: 2010-12-13
Abstract: An arrangement for detecting deformation, in particular bending deflection, of a blade of a wind turbine, is disclosed. The wind turbine comprises a tower, a nacelle, and a rotor. The nacelle, which is disposed on the tower, contains a bearing where the rotor is mounted in the bearing so as to be rotatable about an axis of rotation R. The blade is fixed such that the blade can co-rotate with the rotor about the axis of rotation R. The arrangement incorporates a radio transmitter and an antenna assigned to the radio transmitter where the antenna receives a signal S emitted by the radio transmitter. An evaluation device is provided to receive the signals from the individual antennas. The evaluation device detects, on the basis of the signals fed thereto, an offset of the radio transmitter compared to a normal position where either the radio transmitter is mounted on the blade and the antenna is disposed such that it co-rotates with the rotor and the blade, or the antenna is mounted on the blade and the radio transmitter is disposed such that it co-rotates with the rotor and the blade. The signal receivable by the antenna can be used to detect the position of the radio transmitter relative to the antenna device in the direction of the axis of rotation R for detecting deformation of the blade.
Patent NZ-591179-A (NZ)
Title: Glucagon-like-peptide-2 (glp-2) analogues
Inventor: LARSEN BJARNE DUE
IPC: A61K38/26
Filed: 2006-05-04
Abstract: Provided is a glucagon-like peptide 2 (GLP-2) analogue or a pharmaceutically acceptable salt thereof, wherein said analogue comprises an amino acid sequence represented by the general formula: R1 -Z1 -His-Gly-X3-Gly-X5-Phe-X7-Asp-Glu-Leu-X11-Thr-Ile-Leu-Asp-X16-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Ala-Trp-Leu-lle-X28-Thr-Lys-Z2-R2 wherein: R1 is hydrogen, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl X3 is Glu or Asp X5 is Ser or Thr X7 is Ser or Thr X11 is Asn, Ala, Lys or Ser X16 is Asn or Ala X28 is Gln or Ala R2 is NH2 or OH; and Z1 and Z2 are independently absent or a peptide sequence of 3-20 amino acid units selected from the group consisting of Ala, Leu, Ser, Thr, Tyr, Asn, Gln, Asp, Glu, Lys, Arg, His, Met and Orn. The compound can be used to treat stomach and bowel disorders.
Patent NZ-591279-A (NZ)
Title: Wind turbine with rail-system within the nachelle
Inventor: ERIKSEN UFFE
IPC: B66C23/18
Filed: 2011-02-21
Abstract: A wind turbine (1) comprising a nacelle (3) that is rotatably disposed on a tower (4) is disclosed. The nacelle (3) has a first cavity (5). There is a generator housing portion (6) having a second cavity (7) that is disposed upstream to the nacelle (3). The wind turbine (1) also comprises a hub (8) having a third cavity (9) that is disposed upstream to the generator housing portion (6). Rotor blades (2) of the wind turbine (1) are attached to the hub (8). The first, second and third cavities (5, 7 and 9) communicate with one another. The wind turbine (1) further comprises a rail-system (10) with at least one rail- element (11). The rail- element (11) has a means (12) for lifting and/or transporting. The means (12) for lifting and /or transporting is movable along the rail-system (100). The rail-system (10) at least partially extends through at least two adjacent cavities (5, 7; 7, 9).
Patent NZ-593594-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: WANG XILU
IPC: A61K31/18
Filed: 2010-01-15
Abstract: 593594 Disclosed are sulphonyl substituted benzylamides of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are: 4-[4-(cyclohexylmethyl)-4-methoxypiperidin-1-yl]-N-{ [5-({ (1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl} amino)-4-nitrothien-2-yl]sulfonyl} benzamide; N-{ [5-({ (1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl} amino)-4-nitrothien-2-yl]sulfonyl} -4-[4-methoxy-4-(3-methylbenzyl)piperidin-1-yl]benzamide; N-{ [5-({ (1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl} amino)-4-nitrothien-2-yl]sulfonyl} -4-[4-(3,3-diphenylprop-2-enyl)piperazin-1-yl]benzamide; and 4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-N-({ 2-[(4-fluorotetrahydro-2H-pyran-4-yl)methoxy]-4-methyl-1,3-thiazol-5-yl} sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide. Further disclosed are the use of the compounds in the manufacture of a medicament for treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancy of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer in a patient.
Patent NZ-594753-A (NZ)
Title: Automated device provisioning and activation
Inventor: RALEIGH GREGORY G
IPC: H04W4/24
Filed: 2010-01-18
Abstract: A system and a method for enabling secure control-plane communications with, and adapted for being used together with, an end-user device system adapted for enabling secure control plane communications with the system is disclosed. The system comprises means for providing a plurality of service control links to a plurality of service control device link agents, each service control device link agent on a different one of a plurality of end-user devices communicatively coupled to the system, each service control link secured by an encryption protocol, each service control link supporting control-plane communications between the system and one of the service control device link agents over a wireless access network, each service control device link agent for delivering agent messages over an agent communication bus to a plurality of device agents; means for receiving a server message from a particular server of a plurality of servers coupled to the system, the server message comprising message content and information identifying a particular device agent of the plurality of device agents on a particular end-user device of the plurality of end-user devices; means for generating an encrypted message using an encryption key, the encrypted message comprising the message content and an agent identifier configured to assist a particular service control device link agent on the particular end-user device in delivering the message content to the particular device agent, the encryption key shared between the system and the particular service control device link agent; and means for sending the encrypted message to the particular service control device link agent over a particular service control link of the plurality of service control links.
Patent NZ-594790-A (NZ)
Title: A closure for a container
Inventor: MCDOWELL CRAIG
IPC: B65D47/06
Filed: 2010-01-26
Abstract: A closure (110) for sealing a mouth of a container, such as a bottle. The closure comprises a body (112) adapted to overlie the mouth; and a closure comprising an inner section (26) and an outer section (22). The outer section comprises a first body and a circumferential point of discontinuity (between arms (116)). The inner section comprises a second body and a plurality of fingers (118).
Patent NZ-596825-A (NZ)
Title: Duramycin peptides and their use in imaging
Inventor: THORPE PHILIP E
IPC: A61P3/04
Filed: 2003-07-15
Abstract: 596825 DURAMYCIN PEPTIDES AND THEIR USE IN IMAGING Provided is a composition comprising a detectably labelled peptide that comprises a duramycin peptide operatively attached to an in vivo diagnostic agent. The in vivo diagnostic agent can be a paramagnetic, X-ray imaging or radioactive isotope, e.g. technetium99m
Patent NZ-599067-A (NZ)
Title: Fatty acid niacin conjugates and their uses
Inventor: MILNE JILL C
IPC: A61K31/44
Filed: 2010-08-31
Abstract: 599067 Disclosed herein are fatty acid niacin conjugates of formula I, wherein the variables are defined in the specification; compositions comprising an effective amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid niacin conjugate. Suitable fatty acids include α-linolenic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid, tetracosapentaenoic acid, and tetracosahexaenoic acid. In one embodiment the compound is N-(2-(5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamidoethyl)nicotinamide.
Patent NZ-600472-A (NZ)
Title: Anti-HIV tablet formulations comprising darunavir
Inventor: SMANS GUIDO FRANCISCUS
IPC: A61K9/20
Filed: 2008-07-25
Abstract: Disclosed is a tablet formulation comprising a core containing 0.1 to 1.5 percent by weight (w/w) of colloidal silicon dioxide and 0.4 to 0.9 percent by weight (w/w) of a lubricant, the balance of the core comprising darunavir, a disintegrant and a filler comprising a spray dried mixture of microcrystalline cellulose and colloidal silicon dioxide.
Patent NZ-603111-A (NZ)
Title: Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Inventor: UMANA PABLO
IPC: C12N5/06
Filed: 2002-08-05
Abstract: Disclosed is a glycoengineered antibody that specifically binds the human CD20 antigen, wherein said antibody has a decreased proportion of non-bisected complex oligosaccharides having the m/z value of 1486 Daltons and an increased proportion of bisected hybrid or galactosylated complex oligosaccharides having the m/z values of 1664, 1810, and 1826 Daltons relative to a corresponding, non-glycoengineered anti-CD20 antibody, and wherein the glycoengineered antibody reaches the maximal ADCC activity of the corresponding non-glycoengineered anti-CD20 antibody at an antibody concentration that is approximately five to ten-fold lower as a result of the glycoengineering.